Skip to main content

The Hip in Spinal Muscular Atrophy

  • Chapter
  • First Online:

Abstract

The musculoskeletal burden of spinal muscular atrophy (SMA) primarily involves the hip and spine. The incidence of hip instability is 30–40% and neuromuscular scoliosis is 60–90% in non-ambulatory SMA patients. The intrinsic relationship between hip and spinal deformity often requires concomitant management of the hip and spine to maximize functional and clinical outcomes. This chapter summarizes the non-operative and operative treatments for hip instability and spinal deformity in the SMA population. While hip subluxation/dislocation has traditionally been treated non-operatively in non-ambulatory SMA patients, the intra-thecal administration of Nusinersen has changed the functional and ambulatory prognosis of patients with SMA. Thus, orthopedic surgeons should consider treating hip instability with operative hip reconstruction as the surgical complication and recurrence rate is similar to that in other neuromuscular conditions.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Canavese F, Sussman MD. Strategies of hip management in neuromuscular disorders: Duchenne Muscular Dystrophy, Spinal Muscular Atrophy, Charcot-Marie-Tooth Disease and Arthrogryposis Multiplex Congenita. Hip Int. 2009;19(Suppl 6):S46–52.

    Article  Google Scholar 

  2. Lunn MR, Wang CH. Spinal muscular atrophy. Lancet. 2008;371(9630):2120–33.

    Article  Google Scholar 

  3. Prior TW, Finanger E. Spinal muscular atrophy. In: Adam MP, et al., editors. GeneReviews((R)). Seattle, WA: University of Washington; 1993.

    Google Scholar 

  4. Sporer SM, Smith BG. Hip dislocation in patients with spinal muscular atrophy. J Pediatr Orthop. 2003;23(1):10–4.

    PubMed  Google Scholar 

  5. Shapiro F, Specht L. The diagnosis and orthopaedic treatment of childhood spinal muscular atrophy, peripheral neuropathy, Friedreich ataxia, and arthrogryposis. J Bone Joint Surg Am. 1993;75(11):1699–714.

    Article  CAS  Google Scholar 

  6. Larson J, Snyder J, Troy M, Whitaker AT, Snyder B. Short-term clinical outcomes of hip reconstructive surgery in patients with spinal muscular atrophy. In: American Academy of pediatrics section on orthopedics, November 3, 2018. Orlando, Florida.

    Google Scholar 

  7. Finkel RS, et al. Nusinersen versus sham control in infantile-onset spinal muscular atrophy. N Engl J Med. 2017;377(18):1723–32.

    Article  CAS  Google Scholar 

  8. Lefebvre S, et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell. 1995;80(1):155–65.

    Article  CAS  Google Scholar 

  9. Sugarman EA, et al. Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72,400 specimens. Eur J Hum Genet. 2012;20(1):27–32.

    Article  Google Scholar 

  10. Abresch RT, et al. Assessment of pain and health-related quality of life in slowly progressive neuromuscular disease. Am J Hosp Palliat Care. 2002;19(1):39–48.

    Article  Google Scholar 

  11. Mesfin A, Sponseller PD, Leet AI. Spinal muscular atrophy: manifestations and management. J Am Acad Orthop Surg. 2012;20(6):393–401.

    Article  Google Scholar 

  12. Zenios M, et al. Operative treatment for hip subluxation in spinal muscular atrophy. J Bone Joint Surg Br. 2005;87(11):1541–4.

    Article  CAS  Google Scholar 

  13. Ogino S, Wilson RB. Spinal muscular atrophy: molecular genetics and diagnostics. Expert Rev Mol Diagn. 2004;4(1):15–29.

    Article  CAS  Google Scholar 

  14. Lally C, et al. Indirect estimation of the prevalence of spinal muscular atrophy Type I, II, and III in the United States. Orphanet J Rare Dis. 2017;12(1):175.

    Article  Google Scholar 

  15. Patel J, Shapiro F. Simultaneous progression patterns of scoliosis, pelvic obliquity, and hip subluxation/dislocation in non-ambulatory neuromuscular patients: an approach to deformity documentation. J Child Orthop. 2015;9(5):345–56.

    Article  Google Scholar 

  16. Mercuri E, Bertini E, Iannaccone ST. Childhood spinal muscular atrophy: controversies and challenges. Lancet Neurol. 2012;11(5):443–52.

    Article  Google Scholar 

  17. Phillips DP, et al. Surgical treatment of scoliosis in a spinal muscular atrophy population. Spine (Phila Pa 1976). 1990;15(9):942–5.

    Article  CAS  Google Scholar 

  18. Fujak A, et al. Contractures of the lower extremities in spinal muscular atrophy type II. Descriptive clinical study with retrospective data collection. Ortop Traumatol Rehabil. 2011;13(1):27–36.

    Article  Google Scholar 

  19. Finkel RS, Sejersen T, Mercuri E. 218th ENMC International Workshop, in Revisiting the Consensus on Standards of Care in SMA. Naarden, The Netherlands: ENMC SMA Workshop Study Group; 2016.

    Google Scholar 

  20. Glanzman AM, et al. The Children’s Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND): test development and reliability. Neuromuscul Disord. 2010;20(3):155–61.

    Article  CAS  Google Scholar 

  21. Mazzone E, et al. Six minute walk test in type III spinal muscular atrophy: a 12 month longitudinal study. Neuromuscul Disord. 2013;23(8):624–8.

    Article  CAS  Google Scholar 

  22. Mazzone E, et al. Assessing upper limb function in nonambulant SMA patients: development of a new module. Neuromuscul Disord. 2011;21(6):406–12.

    Article  Google Scholar 

  23. Vuillerot C, et al. Responsiveness of the motor function measure in patients with spinal muscular atrophy. Arch Phys Med Rehabil. 2013;94(8):1555–61.

    Article  Google Scholar 

  24. Montes J, et al. Six-Minute Walk Test demonstrates motor fatigue in spinal muscular atrophy. Neurology. 2010;74(10):833–8.

    Article  CAS  Google Scholar 

  25. Livingston K, et al. Parasol rib deformity in hypotonic neuromuscular scoliosis: a new radiographic definition, and a comparison of short-term treatment outcomes with VEPTR and growing rods. Spine (Phila Pa 1976). 2015;40(13):E780–6.

    Article  Google Scholar 

  26. Evers MM, Toonen LJ, van Roon-Mom WM. Antisense oligonucleotides in therapy for neurodegenerative disorders. Adv Drug Deliv Rev. 2015;87:90–103.

    Article  CAS  Google Scholar 

  27. Mendell JR, et al. Single-dose gene-replacement therapy for spinal muscular atrophy. N Engl J Med. 2017;377(18):1713–22.

    Article  CAS  Google Scholar 

  28. A study for participants with spinal muscular atrophy (SMA) who previously participated in nusinersen (ISIS 396443) investigational studies. (SHINE). https://clinicaltrials.gov/ct2/show/NCT02594124. (Identification No. NCT02594124).

  29. Ruzbarsky JJ, et al. Risk factors and complications in hip reconstruction for nonambulatory patients with cerebral palsy. J Child Orthop. 2013;7(6):487–500.

    Article  Google Scholar 

  30. McHale KA, Bagg M, Nason SS. Treatment of the chronically dislocated hip in adolescents with cerebral palsy with femoral head resection and subtrochanteric valgus osteotomy. J Pediatr Orthop. 1990;10(4):504–9.

    Article  CAS  Google Scholar 

  31. Wang HY, et al. Joint range of motion limitations in children and young adults with spinal muscular atrophy. Arch Phys Med Rehabil. 2004;85(10):1689–93.

    Article  Google Scholar 

  32. Robinson D, et al. Scoliosis and lung function in spinal muscular atrophy. Eur Spine J. 1995;4(5):268–73.

    Article  CAS  Google Scholar 

  33. Chng SY, et al. Pulmonary function and scoliosis in children with spinal muscular atrophy types II and III. J Paediatr Child Health. 2003;39(9):673–6.

    Article  CAS  Google Scholar 

  34. McElroy MJ, et al. Growing rods for scoliosis in spinal muscular atrophy: structural effects, complications, and hospital stays. Spine (Phila Pa 1976). 2011;36(16):1305–11.

    Article  Google Scholar 

  35. Chandran S, et al. Early treatment of scoliosis with growing rods in children with severe spinal muscular atrophy: a preliminary report. J Pediatr Orthop. 2011;31(4):450–4.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jill E. Larson .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Larson, J.E., Snyder, B. (2019). The Hip in Spinal Muscular Atrophy. In: Alshryda, S., Howard, J., Huntley, J., Schoenecker, J. (eds) The Pediatric and Adolescent Hip. Springer, Cham. https://doi.org/10.1007/978-3-030-12003-0_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-12003-0_20

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-12002-3

  • Online ISBN: 978-3-030-12003-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics